Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction
Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that involves the ineffective production ...
Jun 22, 2012
0
0